Polynovo Ltd. operates as a biotechnology company. It designs, develops and manufactures solutions for standalone and combination devices using its NovoSorb biodegradable polymer technology. Its products are NovoPore is used as a dressing in negative pressure wound therapy and Biodegradable Temporising Matrix is a wound dressing intended for treatment of full-thickness wounds. Polynovo was founded on August 12, 1998 and is headquartered in Port Melbourne, Australia.
|Market Price at 20-11-2017||$0.36|
|Price to Earnings Ratio||-22.98|
|Market Capitalisation||$232.14 (million)|
|Return on Equity (ROE)||-45.24%|